A scheduled increase in the taxable wage base for Social Security will impact earnings up to $184,500 next year, altering tax liabilities for higher earners and potentially widening the retirement savings gap for millions.
American Express reported fourth-quarter earnings that slightly trailed analyst forecasts, prompting a share price decline. Despite the near-term miss, the company issued strong forward guidance for 2026 and announced a significant dividend hike, underscoring confidence in its long-term growth trajectory driven by card member spending and fee growth.
Financial planners are urging a shift in mindset: the date on your retirement party invitation matters less than the balance in your investment portfolio. We break down the calculations that show whether you're truly ready to leave the workforce.
HSBC has raised its rating on New Oriental Education & Technology Group (NYSE: EDU) from 'Hold' to 'Buy', following the company's better-than-expected Q2 FY2026 results. The upgrade highlights a robust recovery in core businesses and strategic expansion into new educational initiatives.
Autonomous driving leader Pony AI partners with premium mobility provider Beijing ATBB, aiming to deploy its seventh-generation robotaxis in top-tier cities and key travel hubs, marking a significant step in China's driverless commercialization push.
New unemployment filings in Wisconsin edged higher last week, diverging from a slight national decline and highlighting ongoing labor market fluctuations across states.
A sharp, unexpected jump in wholesale prices complicates the White House's economic narrative and its pressure campaign on the Federal Reserve for rate cuts.
Morgan Stanley and Barclays have both lowered their price targets for Appalachian Basin natural gas leader Antero Resources (AR), citing revised commodity forecasts. Despite the cuts, Morgan Stanley maintains an 'Overweight' rating, signaling continued confidence in the stock's long-term trajectory.
Analysts at Piper Sandler have slightly lowered their price target for Expand Energy (EXE), the natural gas giant formed from a recent mega-merger, reflecting near-term pressures but maintaining a bullish long-term outlook for the sector.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
Amidst a choppy market, value investors are hunting for bargains. We spotlight three companies—Dingdong, Origin Bancorp, and ATRenew—whose current share prices appear significantly disconnected from their estimated intrinsic value, presenting potential opportunities for the discerning investor.
Amid a cautiously optimistic market backdrop, companies where executives hold significant stakes are drawing investor attention. We examine three such firms where insider buying and strategic moves signal confidence in long-term growth.
While major indices hold steady, a search for growth is turning the spotlight onto smaller companies. We examine three small-cap stocks—from insurance to banking to luxury watches—that are posting strong results and navigating unique challenges in the current market.
The White House has backed away from plans to set minimum prices for domestic critical minerals projects, telling industry leaders that ventures must stand on their own financially. The policy reversal, driven by funding uncertainties and market concerns, marks a significant shift in strategy for bolstering the U.S. supply chain.
Regional airline SkyWest, Inc. has locked in multi-year contract extensions with United Airlines and Delta Air Lines for its Embraer E175 aircraft, providing a stable foundation for growth and improved financial visibility. The agreements solidify the company's fleet strategy and partnership with Embraer amid a competitive landscape.
Carnival Corporation & plc sees its shares rally after posting a record $4.5 billion in operating income for fiscal 2025, reinstating a quarterly dividend, and announcing plans to consolidate its dual-listed structure into a single NYSE entity, signaling a renewed focus on shareholder returns and corporate simplicity.
DoubleVerify's nomination for a Digiday award spotlights its News Accelerator initiative, a strategic push to bolster quality journalism and advertiser confidence in digital news environments. The move comes as the industry grapples with brand safety and seeks more transparent ad placements.
Amneal Pharmaceuticals' shares have surged over 64% in the past year, prompting investors to question if the rally still has room to run. A closer look at valuation metrics suggests the generic drugmaker may still be trading at a significant discount to its intrinsic value.
As demand for AI infrastructure surges, Broadcom's custom chip business positions it for sustained growth, with analysts highlighting its potential for long-term portfolio gains despite its absence from some top stock lists.
Despite a sharp pullback following gold's price dip, analysts remain bullish on SSR Mining, citing strong earnings potential and attractive valuation metrics even after its stellar run.
